FDA Clears Solriamfetol (Sunosi) for Narcolepsy, OSA FDA Clears Solriamfetol (Sunosi) for Narcolepsy, OSA

The dual-acting dopamine and norepinephrine reuptake inhibitor showed durable effects in reducing excessive sleepiness in patients with narcolepsy or obstructive sleep apnea.FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news